OTCMKTS:NPHC

Nutra Pharma News Headlines

$0.0031
+0.00 (+24.00 %)
(As of 09/17/2021 03:59 PM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.02
Volume1.71 million shs
Average Volume19.03 million shs
Market Capitalization$20.84 million
P/E RatioN/A
Dividend YieldN/A
Beta3.06

Media Mentions By Week

Nutra Pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NPHC
News Sentiment

0.99

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NPHC Articles
This Week

2

0

NPHC Articles
Average Week

Get Nutra Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NPHC and its competitors with MarketBeat's FREE daily newsletter.

Nutra Pharma (OTCMKTS NPHC) News Headlines Today

SourceHeadline
Nutra Pharma Corp. (OTCMKTS:NPHC) Short Interest Down 98.9% in AugustNutra Pharma Corp. (OTCMKTS:NPHC) Short Interest Down 98.9% in August
americanbankingnews.com - September 14 at 4:56 PM
Short Interest in Nutra Pharma Corp. (OTCMKTS:NPHC) Increases By 9,300.0%Short Interest in Nutra Pharma Corp. (OTCMKTS:NPHC) Increases By 9,300.0%
americanbankingnews.com - August 26 at 2:11 PM
Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter MeasuresNutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures
finance.yahoo.com - July 23 at 9:22 AM
Nutra Pharma Engages Government Affairs Consulting FirmNutra Pharma Engages Government Affairs Consulting Firm
finance.yahoo.com - July 15 at 12:03 PM
Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product OfferingsNutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings
finance.yahoo.com - June 8 at 9:10 AM
Nutra Pharma Corp.Nutra Pharma Corp.
barrons.com - June 5 at 7:42 PM
Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain RelieversNutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers
finance.yahoo.com - June 4 at 8:35 AM
Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain ReliefProfessional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief
finance.yahoo.com - June 2 at 1:53 PM
Nutra Pharma Provides Updates on Improvements of Manufacturing CapabilitiesNutra Pharma Provides Updates on Improvements of Manufacturing Capabilities
finance.yahoo.com - May 27 at 1:45 PM
Nutra Pharma Announces Influencer and Social Media Campaign for Nyloxin and Pet Pain-AwayNutra Pharma Announces Influencer and Social Media Campaign for Nyloxin and Pet Pain-Away
finance.yahoo.com - May 24 at 12:55 PM
Nutra Pharma is Excited to Announce: Luxury Feet now Available on AmazonNutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon
finance.yahoo.com - April 15 at 10:19 AM
Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High HeelsNutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels
finance.yahoo.com - March 16 at 8:55 AM
Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical TrialsNutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials
finance.yahoo.com - March 11 at 1:36 PM
Nutra Pharma Provides Updates on Laboratory Upgrades and CertificationsNutra Pharma Provides Updates on Laboratory Upgrades and Certifications
finance.yahoo.com - February 23 at 10:15 AM
Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property AttorneysNutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys
finance.yahoo.com - February 12 at 12:37 PM
Nutra Pharma Letter to ShareholdersNutra Pharma Letter to Shareholders
finance.yahoo.com - January 12 at 11:35 AM
News for Nutra Pharma CorpNews for Nutra Pharma Corp
markets.businessinsider.com - December 24 at 8:09 AM
Nutra Pharma Provides Updates on Progress of their Nerve Agent CountermeasuresNutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
finance.yahoo.com - November 18 at 3:35 PM
Nutra Pharma Announces Nyloxin Now Available on the Walmart MarketplaceNutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace
finance.yahoo.com - November 11 at 10:01 AM
Nutra Pharma Provides Financing Updates and the Elimination of Institutional DebtNutra Pharma Provides Financing Updates and the Elimination of Institutional Debt
finance.yahoo.com - November 4 at 12:05 PM
Nutra Pharma Provides Business and Compliance UpdatesNutra Pharma Provides Business and Compliance Updates
finance.yahoo.com - November 3 at 10:43 AM
Nutra Pharma Corp. (NPHC)Nutra Pharma Corp. (NPHC)
finance.yahoo.com - March 25 at 10:02 PM
Nutra Pharma Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis (ALS)Nutra Pharma Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
www.bloomberg.com - March 10 at 8:07 AM
Nutra Pharma Provides Updates on Marketing and DistributionNutra Pharma Provides Updates on Marketing and Distribution
finance.yahoo.com - March 3 at 1:21 PM
Nutra Pharma Announces that Nyloxin is Now Available on the iRemedy MarketplaceNutra Pharma Announces that Nyloxin is Now Available on the iRemedy Marketplace
finance.yahoo.com - May 30 at 11:12 AM
Nutra Pharma Responds to FDA Warning LetterNutra Pharma Responds to FDA Warning Letter
finance.yahoo.com - April 10 at 9:44 AM
Nutra Pharma CorpNutra Pharma Corp
www.bloomberg.com - March 19 at 11:44 AM
FDA says Nutra Pharma illegally markets unapproved products claiming to treat addiction and chronic painFDA says Nutra Pharma illegally markets unapproved products claiming to treat addiction and chronic pain
finance.yahoo.com - March 19 at 11:43 AM
Get Nutra Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NPHC and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.